Although novel biomarkers such as circulating tumor DNA (ctDNA) are currently under investigation1, serum carcinoembryonic antigen (CEA) is still the most widely used tumor marker for colorectal cancer (CRC) worldwide2,3. The gene discussed is CEACAM5; the disease is colorectal cancer.